Volume 20, Number 1—January 2014
Dispatch
Rapidly Fatal Hemorrhagic Pneumonia and Group A Streptococcus Serotype M1
Table
Gene | Primer name† | Primer sequence, 5′→3′ | Amplicon size, bp |
---|---|---|---|
Slo | MS442 | GGTAACCTTGTTACTGCTAATGCTGA | 400 |
MS443 | TAATGGAAATATCGACTGGTGTAGTG‡ | 400 | |
speA | speA-fw | CTCAACAAGACCCCGATCCAAG | 500 |
speA-rew | ATTTAGAAGGTCCATTAGTATATAGTTGC‡ | 500 | |
speB | MS384 | GGCATGTCCGCCTACTTTACCGA | 800 |
MS385 | CAGGTGCACGAAGCGCAGAAG‡ | 800 | |
speC | MS410 | TACTGATTTCTACTATTTCACCTATCATC | 447 |
MS411 | TCTGATTTTAAAGTCAATTTCCTGG‡ | 447 | |
speG | MS412 | GCTATGGAAGTCAATTAGCTTATGCAG | 448 |
MS413 | CCGATGTATAACGCGATTCCGA‡ | 448 | |
speI | speI-up | GGTCCGCCATTTTCAGGTAGTTT | 516 |
speI-rew | ACGCATACGAAATCATACCAGTAG‡ | 516 | |
speJ | MS414 | CACTCCTTGTACTAGATGAGGTTGC | 508 |
MS415 | ACGCATACGAAATCATACCAGTAG‡ | 508 | |
sagBC | sagBC-fw | GCAGCTAGTTGCTCAACATTTAATG | 600 |
sagBC | sagBC-rew | CATAGGCAGTCGCCTGATTCC‡ | 600 |
prtF | MS400 | CGGAGTATCAGTAGGACATGCGGA | 882 |
prtF | MS401 | CTCCCACCAACATTGCTTAATCCA‡ | 882 |
PAM | PAM-fw | GCAGACGACGCTAGAAATGAAGTA | 900 |
PAM-rew | CCTGCTTGTGGTGCTTGACCTTTAC‡ | 900 | |
Sof | MS402 | ATGCCTGGTTGGGTATCTTCGGT | 406 |
MS403 | AGAGAACAAAACGTTCTGCGCCTA‡ | 406 | |
Ssa | ssa-fw | GTAGTCAGCCTGACCCTACTCCAGAAC | 621 |
ssa-rew | ACTGATCAAATATTGCTGCAGGTGC‡ | 621 | |
sda1 | MS431 | GGGTCTATAAGAAAAGTGGGCAAAG | 439 |
MS432 | TGATCGTAAAGGTGGGATGCAGTA‡ | 439 |
*slo, streptolysin O; sagA/BC, streptolysin S-associated gene A protein; smeZ-2 mitogenic exotoxin Z; speA, streptococcal pyrogenic toxin A; speB, streptococcal cysteine protease; speC, streptococcal pyrogenic toxin C; speG, streptococcal pyrogenic toxin G; speI, streptococcal pyrogenic toxin I; speJ; streptococcal pyrogenic toxin J; prtF, fibronectin-binding protein; PAM, plasminogen-binding protein; sof serum opacity factor; ssa streptococcal superantigen; sda1, streptodornase D.
†Primers indicated in boldface were created with the VectorNT program (Invitrogen, Carlsbad, CA, USA). Other primers were described by Santagati et al. (11).
‡Reverse primers.
References
- Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685–94. DOIPubMedGoogle Scholar
- Steer AC, Lamagni T, Curtis N, Carapetis JR. Invasive group a streptococcal disease: epidemiology, pathogenesis and management. Drugs. 2012;72:1213–27. DOIPubMedGoogle Scholar
- Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol. 2011;9:724–36. DOIPubMedGoogle Scholar
- Henningham A, Barnett TC, Maamary PG, Walker MJ. Pathogenesis of group A streptococcal infections. Discov Med. 2012;13:329–42 .PubMedGoogle Scholar
- Friães A, Pinto FR, Silva-Costa C, Ramirez M, Melo-Cristino J. Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance. BMC Microbiol. 2012;12:280. DOIPubMedGoogle Scholar
- Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalén C. The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill. 2005;10:179–84 .PubMedGoogle Scholar
- Turner CE, Dryden M, Holden MT, Davies FJ, Lawrenson RA, Farzaneh L, Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes. J Clin Microbiol. 2013;51:2089–95. DOIPubMedGoogle Scholar
- Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis. 2005;192:771–82. DOIPubMedGoogle Scholar
- Herwald H, Cramer H, Mörgelin M, Russell W, Sollenberg U, Norrby-Teglund A, M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell. 2004;116:367–79. DOIPubMedGoogle Scholar
- Uchiyama S, Andreoni F, Schuepbach RA, Nizet V, Zinkernagel AS. DNase Sda1 allows invasive M1T1 group A Streptococcus to prevent TLR9-dependent recognition. PLoS Pathog. 2012;8:e1002736. DOIPubMedGoogle Scholar
- Santagati M, Scillato M, Patane F, Aiello C, Stefani S. Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol. 2012;65:23–31. DOIPubMedGoogle Scholar
- Lassalle S, Hofman V, Butori C, Sicard D, Hofman P. Histological diagnosis of lung bacterial necrotizing infections: a study of four fulminant cases. Ann Pathol. 2005;25:349–56. DOIPubMedGoogle Scholar
- Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med. 2007;13:981–5. DOIPubMedGoogle Scholar
- Kansal RG, McGeer A, Low DE, Norrby-Teglund A, Kotb M. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun. 2000;68:6362–9 . DOIPubMedGoogle Scholar
1These authors contributed equally to this article.
Page created: January 03, 2014
Page updated: January 03, 2014
Page reviewed: January 03, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.